We are live on ! Find out more
BTTX

Better Therapeutics, Inc. Common Stock
BTTX

Delisted

BTTX was delisted on the 15th of March, 2024.

Back to rankings

1 hedge funds and large institutions have $0 invested in Better Therapeutics, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

100% less capital invested

Capital invested by funds: $1 → $0 (-$1)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

BTTX Hedge Fund Activity: Q2 2025 in Review

1 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Better Therapeutics, Inc. Common Stock (BTTX) for Q2 2025, worth a combined $0 — down 100% from $1 a quarter earlier.

Fund positioning in BTTX was balanced in Q2 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Better Therapeutics, Inc. Common Stock (BTTX) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $0 of Better Therapeutics, Inc. Common Stock stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Better Therapeutics, Inc. Common Stock positions in Q2 2025 and 0 closed out.

Based on aggregated 13F filings for Q2 2025.